Allergy/Asthma News

A single therapeutic dose administered on the first day of a drug provocation test could be safe in diagnosing mild nonimmediate reactions to amoxicillin-clavulanic acid, according to a study published in Pediatric Allergy and Immunology.

Factors such as administration setting and demographics impacted adherence to biologic treatment among patients with moderate to severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Clinicians should consider potentially harmful ingredients such as haptens when using moisturizing emollients to prevent atopic dermatitis or food allergy, according to a review published in Clinical and Translational Allergy.

Sleep deprivation and repeat challenges, but not exercise, increased the severity of allergic reactions during peanut oral food challenges, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The NIH launched a clinical trial to assess whether dupilumab can reduce asthma exacerbations and improve lung function and symptoms in children with poorly controlled allergic asthma in low-income urban areas.

Telemedicine offers the promise of increased efficiency during patient care, but in-person evaluations and relationships are too valuable to completely disregard, according to a debate session at EULAR 2022 Congress.

The use of H1 or H2 antihistamines may mitigate some side effects of peanut oral immunotherapy, but they did not influence quality of life, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with cancer undergoing treatment with immune checkpoint inhibitors did not experience exacerbations in their asthma, according to a study published in Annals of Allergy, Asthma & Immunology.

Food allergy and food sensitization in early childhood appeared associated with oral allergy syndrome among children with allergic rhinitis, according to a study published in Pediatric Allergy and Immunology.

Patients with chronic rhinosinusitis with nasal polyps experienced improved sleep and functioning after 52 weeks of treatment with dupilumab, according to research published in The Journal of Allergy and Clinical Immunology: In Practice.